COVID-19 and Sickle Cell Disease in the Province of Quebec, Canada: Outcomes after Two Years of the Pandemic

Background: Patients with sickle cell disease (SCD) are considered at higher risk of severe COVID-19 infection. However, morbidity and mortality rates are variable among countries. To date, there are no published reports that document outcomes of SCD patients with COVID-19 in Canada. Methods: A web-...

Descripción completa

Detalles Bibliográficos
Autores principales: Castonguay, Mathias, Dakhallah, Nawar, Desroches, Justin, Colaiacovo, Marie-Laure, Jimenez-Cortes, Camille, Claveau, Anne-Marie, Bérubé, Samuel, Hafsaoui, Amer Yassine, Souza, Amalia, Tibout, Pauline, Ah-Yan, Christophe, Vincent, Anne-Marie, Naessens, Veronique, Brossard, Josée, Abish, Sharon, Santiago, Raoul, Soulières, Denis, Laroche, Vincent, Pastore, Yves, Tran, Thai Hoa, Forté, Stéphanie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9781039/
https://www.ncbi.nlm.nih.gov/pubmed/36555978
http://dx.doi.org/10.3390/jcm11247361

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9781039/
https://www.ncbi.nlm.nih.gov/pubmed/36555978
http://dx.doi.org/10.3390/jcm11247361

Ejemplares similares